These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15228415)

  • 1. Risk factors for different histological types of ovarian cancer.
    Parazzini F; Chiaffarino F; Negri E; Surace M; Benzi G; Franceschi S; Fedele L; La Vecchia C
    Int J Gynecol Cancer; 2004; 14(3):431-6. PubMed ID: 15228415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Weiderpass E; Persson IR
    J Natl Cancer Inst; 2002 Apr; 94(7):497-504. PubMed ID: 11929950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for ovarian cancers with and without microsatellite instability.
    Segev Y; Pal T; Rosen B; McLaughlin JR; Sellers TA; Risch HA; Zhang S; Sun P; Narod SA; Schildkraut J
    Int J Gynecol Cancer; 2014 May; 24(4):664-9. PubMed ID: 24755492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic types of epithelial ovarian cancer: have they different risk factors?
    Kurian AW; Balise RR; McGuire V; Whittemore AS
    Gynecol Oncol; 2005 Feb; 96(2):520-30. PubMed ID: 15661246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.
    Wentzensen N; Poole EM; Trabert B; White E; Arslan AA; Patel AV; Setiawan VW; Visvanathan K; Weiderpass E; Adami HO; Black A; Bernstein L; Brinton LA; Buring J; Butler LM; Chamosa S; Clendenen TV; Dossus L; Fortner R; Gapstur SM; Gaudet MM; Gram IT; Hartge P; Hoffman-Bolton J; Idahl A; Jones M; Kaaks R; Kirsh V; Koh WP; Lacey JV; Lee IM; Lundin E; Merritt MA; Onland-Moret NC; Peters U; Poynter JN; Rinaldi S; Robien K; Rohan T; Sandler DP; Schairer C; Schouten LJ; Sjöholm LK; Sieri S; Swerdlow A; Tjonneland A; Travis R; Trichopoulou A; van den Brandt PA; Wilkens L; Wolk A; Yang HP; Zeleniuch-Jacquotte A; Tworoger SS
    J Clin Oncol; 2016 Aug; 34(24):2888-98. PubMed ID: 27325851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.
    Huusom LD; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
    Cancer Causes Control; 2006 Aug; 17(6):821-9. PubMed ID: 16783610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for ovarian cancer histotypes.
    Chiaffarino F; Parazzini F; Bosetti C; Franceschi S; Talamini R; Canzonieri V; Montella M; Ramazzotti V; Franceschi S; La Vecchia C
    Eur J Cancer; 2007 May; 43(7):1208-13. PubMed ID: 17376671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for ovarian cancers with and without microsatellite instability.
    Segev Y; Pal T; Rosen B; McLaughlin JR; Sellers TA; Risch HA; Zhang S; Ping S; Narod SA; Schildkraut J
    Int J Gynecol Cancer; 2013 Jul; 23(6):1010-5. PubMed ID: 23748177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endometriosis as a risk factor for ovarian cancer].
    Vargas-Hernández VM
    Cir Cir; 2013; 81(2):163-8. PubMed ID: 23522320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts.
    Jung S; Allen N; Arslan AA; Baglietto L; Barricarte A; Brinton LA; Egleston BL; Falk RT; Fortner RT; Helzlsouer KJ; Gao Y; Idahl A; Kaaks R; Krogh V; Merritt MA; Lundin E; Onland-Moret NC; Rinaldi S; Schock H; Shu XO; Sluss PM; Staats PN; Sacerdote C; Travis RC; Tjønneland A; Trichopoulou A; Tworoger SS; Visvanathan K; Weiderpass E; Zeleniuch-Jacquotte A; Dorgan JF
    Int J Cancer; 2018 Jan; 142(2):262-270. PubMed ID: 28921520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does smoking increase risk of ovarian cancer? A systematic review.
    Jordan SJ; Whiteman DC; Purdie DM; Green AC; Webb PM
    Gynecol Oncol; 2006 Dec; 103(3):1122-9. PubMed ID: 17005245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body size and risk of epithelial ovarian and related cancers: a population-based case-control study.
    Olsen CM; Nagle CM; Whiteman DC; Purdie DM; Green AC; Webb PM
    Int J Cancer; 2008 Jul; 123(2):450-456. PubMed ID: 18449887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological aspects of ovarian malignancies in North Sardinia in the period 1992-2001.
    Cossu A; Budroni M; Capobianco G; Pirino D; Palmieri G; Dessole S; Tanda F; Cesaraccio R; Cherchi PL
    Eur J Gynaecol Oncol; 2005; 26(1):47-50. PubMed ID: 15755000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
    Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
    Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of ovarian endometriosis in epithelial ovarian cancer.
    Jimbo H; Yoshikawa H; Onda T; Yasugi T; Sakamoto A; Taketani Y
    Int J Gynaecol Obstet; 1997 Dec; 59(3):245-50. PubMed ID: 9486515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
    Jordan SJ; Green AC; Whiteman DC; Webb PM;
    Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Origin of ovarian cancer from benign cysts.
    Dal Maso L; Canzonieri V; Talamini R; Franceschi S; La Vecchia C
    Eur J Cancer Prev; 2001 Apr; 10(2):197-9. PubMed ID: 11330466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose aspirin use and the risk of ovarian cancer in Denmark.
    Baandrup L; Kjaer SK; Olsen JH; Dehlendorff C; Friis S
    Ann Oncol; 2015 Apr; 26(4):787-792. PubMed ID: 25538177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study.
    Soegaard M; Jensen A; Høgdall E; Christensen L; Høgdall C; Blaakaer J; Kjaer SK
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1160-6. PubMed ID: 17548679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population attributable fractions for ovarian cancer in Swedish women by morphological type.
    Granström C; Sundquist J; Hemminki K
    Br J Cancer; 2008 Jan; 98(1):199-205. PubMed ID: 18071361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.